Although many infectious agents have been implicated in the etiology of diarrhea in young calves, four microorganisms stand out as being of widespread occurrence and proven enteropathogenicity: rotavirus, coronavirus, enterotoxigenic Escherichia coli (ETEC), and cryptosporidia (2, 8, 10, 11, 23) .
Control of diarrhea has been attempted with a live attenuated rotavirus-coronavirus vaccine for oral inoculation of newborn calves (Scourvax-II; Norden Laboratories) but has not been proven effective in blind field trials (3, 9) . Control can also be attempted through dam vaccination to elevate the titers of specific antibody ingested by the calf in colostrum and milk. Such an approach has been used successfully with both bacterins and with K99 phli from ETEC (1, 14, 15) , although live attenuated rotavirus-coronavirus vaccination of pregnant cows (Calf Guard; Norden Laboratories) does not significantly raise milk antibody titers (L. L. Myers and D. R. Snodgrass, J. Am. Vet. Med. Assoc., in press). The use of inactivated adjuvanted rotavirus vaccine results in greatly increased colostrum and milk antibody production (20, 21) .
The objectives of this study were to combine K99 pili from ETEC with a rotavirus vaccine for pregnant cows and to assess the efficacy by serology and by challenging newborn calves with ETEC.
MATERIALS AND METHODS Animals. A total of 24 pregnant hill suckler cows from 7 to 15 years of age were allocated to treatment groups at 4 to 10 weeks before calving. Six cows were vaccinated once with 2 ml of oil-adjuvanted vaccine by deep intramuscular injection in the neck; six cows were similarly vaccinated once with 0.5 ml of the same oil-adjuvanted vaccine; six cows were vaccinated twice with a 4-week interval with 4 ml of aluminum hydroxide-adjuvanted vaccine by deep intramuscular injection in the neck; and six cows were not vaccinated. Four of the cows allocated to the control group had been vaccinated with rotavirus-coronavirus vaccine in their previous pregnancy and were included as controls only for the ETEC component.
The cows were housed before calving for the duration of the experiment. Calves were challenged with ETEC between 6 and 18 h after birth. After challenge, cow-calf pairs from the different treatment groups were kept apart for at least 3 days to prevent crosssuckling and then were moved to a pen separate from that of the uncalved cows. 8 h and then on Minca-IsoVitaleX (BBL) (6) agar for 18 h at 37°C. The bacteria were suspended in phosphate-buffered saline with 10%o dimethyl sulfoxide and stored in 10-ml aliquots at -700C.
To inoculate each calf, one 10-ml aliquot was thawed and given orally by syringe. The mean inoculum titer was 4.1 x 1010 colony-forming units per 10 ml (range, 3.0 x 1010 to 6.8 x 1010 colony-forming units per 10 ml). No decrease in the inoculum titer occurred over the 2-month experimental period. The enteropathogenicity of the stored organisms was confirmed periodically by slide agglutination for K99 and the infant mouse test for heat-stable toxin production (4).
K99 serology. Antibodies to K99 were assayed by enzyme-linked immunosorbent assay (ELISA) or passive hemagglutination (PHA). The ELISA utilized rabbit anti-K99 immunoglobulin G (kindly supplied by W. H. Jansen) as capture antibody, followed successively by K99 antigen, test serum or whey, and rabbit anti-bovine immunoglobulin G (Miles Laboratories, Inc.) conjugated with alkaline phosphatase. The final phosphatase substrate (Sigma Chemical Co.) reaction was read at 405 nm after 2 h at room temperature. In each test, doubling dilutions of a standard bovine anti-K99 serum were included. The titers of the test samples are expressed in relation to a calibration curve calculated from the standards.
In the PHA assay, pyruvic acid-stabilized sheep erythrocytes (7) were sensitized with K99 antigen from ETEC 4. A suspension of erythrocytes in 0.1 M acetate buffer (pH 4.5) was coated to saturation with K99 derived by the method of Morris et al. (12) , washed five times in phosphate-buffered saline (pH 7.5), and resuspended to 1% (vol/vol). Test sera and whey samples were adsorbed with an equal volume of packed unsensitized erythrocytes for 18 h at 40C to remove nonspecific hemagglutinins. Serial doubling dilutions of serum or whey samples in 0.3% Formol saline were prepared in microtiter plates, and an equal volume (0.025 ml) of sensitized erythrocytes was added. The agglutination pattern was read after 18 h of incubation at 37°C. All of the samples were tested on one occasion, although repeat tests on selected samples yielded the same titers.
Rotavirus serology. Serum samples, whey from colostrum samples, and whey from milk samples were tested for the presence of neutralizing antibody to tissue culture-adapted calf rotavirus on bovine embryo kidney cells or MA104 cells grown in microtiter plates.
Titration of K99 antigen. The titration method used is based on the capacity of the K99 antigen to adsorb K99 antibodies from a standard antiserum of known titer, which is then titrated for residual antibody by PHA. This method is based on an in vitro assay designed for quantitating K88 antigens of E. coli (16) . The results are expressed as agglutinin absorbing units. The standard antiserum used was produced in a pig vaccinated with a sterile culture supernatant of The toxicity of the K99 vaccine preparations was examined by injecting groups of 10 mice intraperitoneally with 15 U of alhydrogel-adsorbed K99 and 180 U of crude K99 extract.
Feces examination. Calf feces samples were examined for rotavirus by ELISA (5) and for cryptosporidia by examination of Giemsa-stained fecal smears (19) . Samples were cultured on Minca-IsoVitaleX (6) and MacConkey agars overnight aerobically at 37°C. Five colonies grown on Minca-IsoVitaleX agar were tested for K99 by slide agglutination with rabbit antiserum to strain K12:K99 adsorbed with the K12 strain.
At intervals, fecal swabs from all calves were tested for the presence of Salmonella spp. after overnight enrichment in Selenite broth and for Campylobacter spp. by growth on 5% sheep blood agar plus Skirrows antibiotic supplement (Oxoid Ltd.) under microaerophilic conditions at 37°C.
Observations. Each cow was bled for serum at vaccination, 4 weeks after vaccination, at parturition, and 28 days after parturition. Colostrum and milk samples were collected at 1, 3, 7, 14, 28, and 90 days after calving. The calves were bled for serum at 3 and 28 days of age. Feces samples were collected from the calves daily for 6 days. A sample of these feces was taken for microbiological examination, and the remainder was dried to constant weight for dry-matter estimation. The calves were weighed at 1, 2, and 3 days of age. All calves were examined clinically at least once a day for 6 days and assigned a clinical score on a subjective scale similar to that used by Myers (14) : (i) normal, feces firm; (ii) transient diarrhea within 24 h of inoculation, lasting only a few hours; (iii) severe watery diarrhea, calf becoming dehydrated and dull; (iv) severe watery diarrhea, calf too weak to stand, with death ensuing. RESULTS K99 immunological response measured by ELISA. Six cows had low preexisting serum antibody (mean titer, 158), whereas all other cows were negative (titer < 100). All vaccine regimes significantly increased serum antibody titers (P < 0.001) ( Table 1) , although oil vaccines produced significantly higher titers at calving (18, 900 and 8,830 for 2-and 0.5-ml doses, respectively) than did the alhydrogel vaccine (1,190) (P < 0.001).
Both 2-and 0.5-ml doses of oil vaccine produced very high titers in colostral whey (32,100 and 19,800, respectively) compared with controls (108) (P < 0.001). These colostral antibody levels declined slowly throughout the 28-day observation period, but remained significantly higher than in the controls (2 ml of oil, P < 0.001; 0.5 ml of oil, P < 0.05). Antibody titers in colostral whey from the cows vaccinated with alhydrogel vaccine were also increased (1,140, P < 0.001), but by 7 days after calving, antibody was no longer detectable in this group.
The serum antibody titers in 3-day-old calves reflected the colostral antibody titers of their dams. By 28 days of age, the calves born to K99 immunological response measured by PHA. The assay of sera and wheys by PHA confirmed the results obtained by ELISA (Fig.  1) . In addition, the cow sera collected 28 days after calving were tested, and K99 antibody titers were found to be still significantly raised in all vaccinated cows.
Rotavirus immunological response. The results from the four control cows which had been vaccinated in a previous pregnancy are excluded from these results, and data from seven extra control cows from the same farm not otherwise included in the experiment are incorporated. All cows had prevaccination serum antibody to rotavirus. The serum and milk antibody responses of cows to both doses of oil-adjuvanted vaccine were significant (Table 2) .
Cows vaccinated with alhydrogel-adjuvanted vaccine had raised antibody titers in serum and milk, but only colostral antibody titers were significantly higher than in control cows.
Response of calves to ETEC challenge. After ETEC challenge, five of six calves from control cows developed acute enteric disease (disease rating iii or iv) characterized by profuse watery diarrhea, dehydration, and dullness (Table 3) . The mean body weight loss of 5.7% and the mean minimum fecal dry matter of 8.4% confirmed the severity of the disease. One calf died 2 days after challenge.
The clinical responses of calves in all three 
DISCUSSION
Calves sucking dams vaccinated with K99 pili in any of the schedules used were protected against the clinical effects of challenge with ETEC, whereas the same challenge produced severe enterotoxic colibacillosis in calves from control cows. In addition, excretion of the challenge strain was significantly reduced in calves from vaccinated cows. Although the oil vaccines produced a much higher immunological response than the alhydrogel vaccine, the degree of protection under these experimental conditions was equally satisfactory.
Most natural ETEC infections occur in calves 1 to 2 days old (2, 10) , and increased antibody titers in colostrum alone should be protective in these cases. However, there is experimental evidence that initial rotavirus infection can facilitate ETEC colonization in calves up to 1 week old (17, 20a) , and such dual infection of older calves has been reported to occur naturally (10) . For this reason, it is desirable to stimulate production of K99 antibody in milk as well as in colostrum, and the oil-adjuvanted vaccine formulation was more effective in this regard than the alhydrogel vaccine. The mean K99 ELISA titers of 7-day milk of cows vaccinated with either dose of the oil-adjuvanted vaccine were higher than those in colostrum of cows which received the alhydrogel-adjuvanted vaccine. As calves of the latter group of cows were resistant to experimental challenge, it is reasonable to suggest that cows vaccinated with oil-based K99 vaccine would confer protection to their calves for at least 7 days and probably longer.
With the methods of vaccine production used with strain B41 (0101:K-:K99) it is likely that antigens other than K99 were present, in particular the 0101 somatic antigen and an anionic adhesin (13). However, cross-protection against a Mean number of colonies agglutinated by K99 antiserum as a percentage of the total number of colonies tested over the 6 days after challenge.
b Differs significantly from control (P < 0.05). c Differs significantly from control (P < 0.01).
the challenge strain 09:K30:K99 suggests that effective protection was produced in this case by K99 antibodies, even against a strain which may possess colonization properties through K30 (18) . These results confirm those of others who have found that antibody to K99 protects against virulent ETEC challenge (1, 15). However, the incorporation of a rotavirus vaccine greatly increases the value of the immunization regime. No rotavirus challenge was included, but the rotavirus serological response produced in this experiment by the oil-adjuvanted vaccines was consistent with that produced previously, which has been shown to confer substantial protection against rotavirus infection (5, 20, 21) . Thus, there was no evidence that the inclusion of K99 interfered with the maternal response to rotavirus vaccination.
An effective bivalent vaccine against ETEC and rotavirus would not prevent all calf diarrhea outbreaks. In particular, disease due to calf coronavirus would continue, as has been found with a previous rotavirus vaccine (22) , and cryptosporidiosis would continue to be present. However, the use of such a vaccine could be expected to lead to a useful reduction in morbidity and mortality from diarrhea in young suckled calves and potentially in dairy calves also if the duration of colostrum feeding was prolonged (21) .
